Skip to main content
. 2019 May 27;5(4):239–246. doi: 10.1159/000497353

Table 5.

Comparison between different pathological groups in patients with secondary FSGS

Parameter Patients,n Plasma suPAR levela, pg/mL p value
S
  <13% 23 2,952.6 (2,551.6–4,211.9) 0.042
  ≥ 13% 25 3,669.3 (3,129.4–4,583.4)

SS/NS
  <15.5% 24 4,003.1 (2,634.8–4,521.6) 0.42
  ≥ 15.5% 24 3,163.6 (2,752.3–4,323.3)

RTa/RIf
  1 18 3,100.9 (2,695.0–4,487.8) 0.48
  2 30 3,391.2 (2,766.7–4,530.0)

Total sclerosis
  <16% 23 4,211.9 (2,597.5–5,088.4) 0.20
≥ 16% 25 3,291.7 (2,769.5–3,882.7)

S, global sclerosis in glomeruli; SS/NS, segmental or nodular sclerosis in glomeruli; RTa/RIf, renal tubular atrophy/renal interstitial fibrosis ratio.

a

Median (25th–75th percentile).